Advanced search
Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 49, 2019 - Issue 11
Submit an article Journal homepage
146
Views
2
CrossRef citations to date
0
Altmetric
Animal Pharmacokinetics and Metabolism

Pharmacokinetics of S-EPA, and its inhibition on indoleamine 2,3-dioxgenase: a case of sulfur-substitution affecting distributions in blood cells

Wenyan WangMinistry of Education, School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong Yantai University, Yantai, PR China; Correspondence[email protected] [email protected]
View further author information
,
Xuhui ZhuangMinistry of Education, School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong Yantai University, Yantai, PR China; View further author information
,
Heyuan SunMinistry of Education, School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong Yantai University, Yantai, PR China; View further author information
,
Lina DongMinistry of Education, School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong Yantai University, Yantai, PR China; View further author information
,
Zongliang LiuMinistry of Education, School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong Yantai University, Yantai, PR China; View further author information
,
Guangying DuMinistry of Education, School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong Yantai University, Yantai, PR China; View further author information
,
Liang YeInstitute of Toxcicology, Binzhou Medical University, Yantai, PR ChinaView further author information
&
Jingwei TianMinistry of Education, School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong Yantai University, Yantai, PR China; View further author information
 show all
Pages 1338-1343 | Received 29 Sep 2018, Accepted 05 Nov 2018, Published online: 17 Dec 2018

References

  • Akagi H, Reynolds A, Hjelm M. (1991). Cyclosporin A and its metabolites, distribution in blood and tissues. J Int Med Res 19:1–18.
  • Boer J, Young-Sciame R, Lee F, et al. (2016). Roles of UGT, P450, and Gut microbiota in the metabolism of epacadostat in humans. Drug Metab Dispos 44:1668–74.
  • Efimov I, Basran J, Thackray SJ, et al. (2011). Structure and reaction mechanism in the heme dioxygenases. Biochemistry 50:2717–24.
  • Gangadhar TC, Hamid O, Smith DC, et al. (2015). Preliminary results from a phase I/II study of epacadostat (INCB024360) in combination with pembrolizumab in patients with selected advanced cancers. J Immunother Cancer 3:O7. doi:10.1186/2051-1426-3-S2-O7.
  • Jochems C, Fantini M, Fernando RI, et al. (2016). The IDO1 selective inhibitor epacadostat enhances dendritic cell immunogenicity and lytic ability of tumor antigen-specific T cells . Oncotarget 7:37762–72.
  • Koblish HK, Hansbury MJ, Bowman KJ, et al. (2010). Hydroxyamidine inhibitors of indoleamine-2,3-dioxygenase potently suppress systemic tryptophan catabolism and the growth of IDO-expressing tumors. Mol Cancer Ther 9:489–98.
  • Macchiarulo A, Camaioni E, Nuti R, Pellicciari R. (2009). Highlights at the gate of tryptophan catabolism: a review on the mechanisms of activation and regulation of indoleamine 2,3-dioxygenase (IDO), a novel target in cancer disease. Amino Acids 37:219–29.
  • Maliniemi P, Laukkanen K, Väkevä L, et al. (2017). Biological and clinical significance of tryptophan-catabolizing enzymes in cutaneous T-cell lymphomas. Oncoimmunology 6:e1273310
  • Meng X, Du G, Ye L, et al. (2017). Combinatorial antitumor effects of indoleamine 2,3-dioxygenase inhibitor NLG919 and paclitaxel in a murine B16-F10 melanoma model. Int J Immunopathol Pharmacol 30:215–26.
  • Moon YW, Hajjar J, Hwu P, Naing A. (2015). Targeting the indoleamine 2,3-dioxygenase pathway in cancer. J Immunother Cancer 3:51..
  • Nam KH, Smith AS, Lone S, et al. (2015). Biomimetic 3D tissue models for advanced high-throughput drug screening. J Lab Autom 20:201–15.
  • Röhrig UF, Majjigapu SR, Vogel P, et al. (2015a). High-throughtput analysis of behavior for drug discovery. Eur J Pharmacol 750:82–9.
  • Röhrig UF, Majjigapu SR, Vogel P, et al. (2015). Challenges in the discovery of indoleamine 2,3-dioxygenase 1 (IDO1) Inhibitors. J Med Chem 58:9421–37.
  • Selvan SR, Dowling JP, Kelly WK, Lin J. (2016). Indoleamine 2,3-dioxygenase (IDO): biology and target in cancer immunotherapies. Curr Cancer Drug Targets 16:755–64.
  • Sugimoto H, Oda S, Otsuki T, et al. (2006). Crystal structure of human indoleamine 2,3-dioxygenase: Catalytic mechanism of O2 incorporation by a heme-containing dioxygenase. Proc Natl Acad Sci U S A 103:2611–6.
  • Takamatsu M, Hirata A, Ohtaki H, et al. (2015). Inhibition of indoleamine 2,3-dioxygenase 1 expression alters immune response in colon tumor microenvironment in mice. Cancer Sci 106:1008–15.
  • Undre NA. (2003). Pharmacokinetics of tacrolimus-based combination therapies. Nephrol Dial Transplant 18:i12–5.
  • Vacchelli E, Aranda F, Eggermont A, et al. (2014). Trial watch: IDO inhibitors in cancer therapy. OncoImmunology 3:e957994.
  • Wang W, Zhuang X, Liu W, et al. (2018). Determination of kynurnine and tryptophan, biomarkers of indoleamine dioxygenase by LC-MS/MS in plasma and tumor. Bioanalysis 2:3.
  • Yue EW, Sparks R, Polam P, et al. (2017). INCB24360 (Epacadostat), a highly potent and selective indoleamine-2,3-dioxygenase 1 (IDO1) inhibitor for immunooncology. ACS Med Chem Lett 8:486–91.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.